Lanean...
Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease worldwide. Despite its high prevalence and rising incidence, there are currently no specific targeted pharmacotherapies approved by the Food and Drug Administration (FDA) for nonalcoholic steatohepatitis (NASH). Cur...
Gorde:
| Argitaratua izan da: | J Clin Exp Hepatol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6926203/ https://ncbi.nlm.nih.gov/pubmed/31889754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2019.06.003 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|